ARTL   $1.24  7.83% Market Closed

Artelo Biosciences Inc
Total Cash 5.60M
totalCashPerShare 1.736
EBITDA
Total Debt 120.00K
quickRatio 5.96
currentRatio 6.562
Total Revenue
debtToEquity 1.644
Revenue/Share
ROA -0.54333997
ROE -0.88581
grossProfits
freeCashflow -5.61M
operatingCashflow -9.40M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.77M
forwardPE -1.3615909
floatShares 3.20M
sharesOutstanding 3.23M
sharesShort 33.26K
sharesShortPriorMonth 45.81K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.01%
Short Ratio help_outline 4.77%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.261
Price To Book help_outline 0.53
earningsQuarterlyGrowth
netIncomeToCommon -10.44M
trailingEps -3.35%
forwardEps -0.88%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46 3Q 2024
institutionsCount 6
lastUpdated Oct. 21, 2024, 9:39 p.m.